Tag: Raymond C. Harris, MD, FASN

KIDNEY HEALTH INITIATIVE URGES INVESTIGATORS TO INCLUDE PEOPLE WITH KIDNEY DISEASES IN CLINICAL TRIALS FOR CORONAVIRUS 2019 (COVID-19) THERAPIES

sarah JonasPolicy

People with kidney diseases are often excluded from clinical trials because of the complexity and high morbidity of kidney disease.

COVID-19 puts people with kidney diseases at a two to sixteen-fold increased risk of severe symptoms.

All investigators should include people with kidney diseases when developing vaccines, preventative therapies or treatments related to COVID-19.

KIDNEY HEALTH INITIATIVE URGES THE ACCELERATION OF HOME THERAPY TECHNOLOGY IN RESPONSE TO CORONAVIRUS 2019 (COVID-19)

sarah JonasPolicy

The COVID-19 pandemic highlights the vulnerability of people with kidney failure who rely on in-center hemodialysis. People with kidney failure are at high risk of severe COVID-19 complications and are exposed to infection due to a kidney replacement therapy process that requires traveling to a dialysis facility multiple times a week.